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Background: Porous biphasic calcium phosphate (BCP) ceramics exhibit good biocompatibility and bone conduction
but are not inherently osteoinductive. To overcome this disadvantage, we coated conventional porous BCP ceramics
with nano-hydroxyapatite (nHA). nHA was chosen as a coating material due to its high osteoinductive potential.
Methods: We used a hydrothermal deposition method to coat conventional porous BCP ceramics with nHA and
assessed the effects of the coating on the physical and mechanical properties of the underlying BCP. Next, its effects
on mesenchymal stem cell (MSC) attachment, proliferation, viability, and osteogenic differentiation were investigated.
Results: nHA formed a deposited layer on the BCP surface, and synthesized nHA had a rod-like shape with lengths
ranging from ~50–200 nm and diameters from ~15–30 mm. The nHA coating did not significantly affect the
density, porosity, flexural strength, or compressive strength of the underlying BCP (P > 0.1). Scanning electron
microscopy showed MSC attachment to the scaffolds, with a healthy morphology and anchorage to nHA crystals via
cytoplasmic processes. The densities of MSCs attached on BCP and nHA-coated BCP scaffolds were 62 ± 26 cells/mm2
and 63 ± 27 cells/mm2 (P > 0.1), respectively, after 1 day and 415 ± 62 cells/mm2 and 541 ± 35 cells/mm2 (P < 0.05)
respectively, after 14 days. According to an MTT assay, MSC viability was higher on nHA-coated BCP scaffolds than on
BCP scaffolds (P < 0.05). In addition, MSCs on nHA-coated BCP scaffolds produced more alkaline
phosphatase, collagen type I, and osteocalcin than MSCs on BCP scaffolds (P < 0.05).
Conclusions: Our results demonstrate that BCP scaffolds coated with nHA were more conducive for MSC adhesion,
proliferation, and osteogenic differentiation than conventional, uncoated BCP scaffolds, indicating that nHA coating
can enhance the osteoinductive potential of BCP ceramics, making this material more suitable for applications in bone
tissue engineering.
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NanotopographyBackground
Bone defects induced by trauma, surgery, or tumor resec-
tion are very common and thus consume a large amount
of medical resources annually. About 9 million fragility
fractures occur worldwide every year [1]. In 2005, in the
United States alone, 1 million trauma fracture patients re-
quired hospitalization, 300,000 cases of spinal fusion sur-
gery cost more than $20 billion in medical resources, and* Correspondence: hongbinlu@hotmail.com
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unless otherwise stated.treatment of more than 3,000 pediatric patients with bone
cancer cost more than $70 million [2]. Autogenous bone
grafting is the gold standard for treating bone defects, but
sources of donor tissue are limited. Furthermore, autolo-
gous bone grafts have shown considerable bone resorption
before bone healing [3,4]. Bone allografts are not exten-
sively applied in clinical practice due to the associated
risks of infection and immune rejection [5,6]. Therefore,
synthetic materials have been studied extensively as po-
tential bone substitutes, including calcium phosphate
(CaP) ceramics [7-9]. One CaP ceramic material, biphasic
calcium phosphate (BCP), is composed of hydroxyapatiteThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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good biocompatibility and bone conduction performance
[10,11]. In addition, BCP degradation and biological activ-
ity can be controlled by adjusting the ratio of HA to
β-TCP [11,12]. However, due to a lack of inherent osteoin-
ductivity [11,13], limited formation of new bone occurs
after osteoconduction is achieved, and thus, conventional
BCP often requires the additional use of osteoinductive
biomolecules (e.g., bone morphogenetic proteins) for en-
hanced osteoinduction [9-11,14].
In recent years, nanotechnology has been applied to the
development of CaP ceramics for bone regeneration [15].
It was discovered that human bone apatite is composed of
nanosized CaP crystals and that nano-hydroxyapatite
(nHA) is similar to the inorganic component of human
bone [9,16]. A nHA surface, such as the previously applied
nHA particles, nHA-coated nHA/gelatin, nHA-coated
roughened titanium, can not only promote the adhesion,
proliferation, and osteogenic differentiation of bone-related
cells and improve mineral deposition [17-21], but also can
improve the biocompatibility, biological activity, and bone
integration ability of the underlying biomaterial [20-22]. In
addition, compared to conventional BCP ceramics, those
with a nanostructured surface have greater osteoinductive
potential [9,23]. Considering these findings along with the
interconnected porous structure of human bone [16], the
present study aimed to improve upon existing bioceramic
materials by coating porous BCP ceramics with nHA to
form a new bioresorbable ceramic scaffold that simulates
the chemical characteristics and physical structure of hu-
man bone on both the macro-and micro-scales.
As a potentially unlimited source of donor tissue, stem
cells offer immense promise for bone repair and regener-
ation [24], and mesenchymal stem cells (MSCs) can be in-
duced to differentiate into bone, amongst other tissues
[25]. MSCs can be harvested from a patient’s bone mar-
row, expanded in culture, induced to differentiate, and
seeded on a biomaterial scaffold prior to implantation into
a bone defect [24,26,27]. MSCs have been widely used to
test potential scaffolds formed from various biomaterials,
such as calcium phosphate cement [24], hydroxyapatite
[17], and silk gland fibroin protein [26]. In the present
study, we compared the osteogenic differentiation of
MSCs seeded on our nHA-coated porous BCP scaffolds as
well as on conventional BCP scaffolds. We hypothesized
that the nHA coating on porous BCP ceramics would pro-
mote the proliferation, viability, and osteogenic differenti-
ation of MSCs, thus demonstrating the osteoinductivity of
this new biomaterial scaffold.
Methods
Preparation of nHA-coated, porous BCP ceramics
Clinical grade porous BCP ceramics were produced by
Gong-Chuang Biofunctional Materials Co., Ltd, Hengyang,China. The specimens used for cell studies were discs of
11 mm in diameter and 2 mm in thickness, those for the
flexural strength testing were 5 × 8 × 25-mm cuboids, and
those for compressive strength testing were 5 × 5 × 12.5-
mm cuboids. All specimens were polished with SiC sand
paper (1500 grit), washed with anhydrous ethanol for
30 minutes in an ultrasonic cleaner, and then rinsed with
deionized water prior to use.
A hydrothermal deposition method was applied to
prepare nHA for coating, using analytical grade reagents
purchased from Alfa Aesar. First, 0.3 mol/L ammonium
dihydrogen phosphate and 0.5 mol/L nitrate tetrahydrate
calcium solution were prepared in deionized water. Then
20 g PVP (polyvinylpyrrolidone) was added to the am-
monium dihydrogen phosphate solution, which was
heated with stirring until the PVP was completely dis-
solved, and after the pH value of the solution had been
adjusted to 11 with concentrated aqueous ammonia,
BCP was added to the solution. Calcium nitrate tetrahy-
drate solution was added under ultrasonic irradiation at
a rate of 2 mL/min into the above reaction mixture, with
continued ultrasound for 30 minutes, and the resulting
mixture was transferred to the hydrothermal synthesis
reactor (Qiang-Qiang Instruments, Shanghai, China) and
maintained under hydrothermal conditions at 120°C for
12 hours. After completion of the reaction, the reaction
vessel was naturally cooled to room temperature, and then
the nHA-coated, porous BCP ceramic samples were re-
moved, filtered, washed with anhydrous ethanol and dis-
tilled water alternately, and dried at room temperature
before being ready for use.
Microstructure characterization
After completion of the reaction, the precipitate was
washed completely with ethanol to remove residual PVP
molecules, collected, and dried at 60°C in a vacuum
oven. Then a small amount of precipitate was ultrasonic-
ally dispersed in anhydrous ethanol, and a drop was
taken and dripped onto an ultra-thin carbon film. After
drying, the size and shape of the nHA were observed
using field emission transmission electron microscopy
(FETEM, JEM-2100 F, JEOL, Tokyo, Japan), and the
morphology of the coating and pore size distribution on the
material surface and section pore wall were observed using
field emission scanning electron microscopy (FESEM, Nova
NanoSEM 230, FEI Co., Hillsboro, OR, USA). For micro-
structure characterization, five view fields were examined on
each of 12 samples for each specimen (60 fields in total).
The phase compositions of the BCP and nHA-coated BCP
surfaces were characterized using X-ray diffraction (XRD,
D/ruax 2550PC, Rigaku, Japan).
The density and porosity of the specimens were mea-
sured according to Archimedes’ method. First, the speci-
men was dried in a vacuum oven at 60°C for 24 hours to
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transferred to a beaker and placed in a vacuum oven at
2 kPa for 15 minutes, followed by slow injection with
water until the specimen was completely immersed. Next,
the pressure was gradually restored to atmospheric, and
then the saturated specimen was placed in a copper wire
basket, suspended in a beaker filled with water, and
weighed (W2). The specimen was taken out of the water,
any water remaining on its surface was removed with wet
gauze, and the specimen was weighed again (W3). The
porosity was calculated using the following formula:
porosity (%) = [(W3 – W1) / (W3 – W2)] × 100%. The
density was calculated using the following formula: density
(g/cm3) = [W1/(W3 – W2)] × d, where d is the density of
water (1 g/cm3).
Characterization of the mechanical properties
The compressive strength of the specimens was tested
using a universal testing machine (Dual Column Testing
System 3369, Instron Co., Norwood, MA, USA) with a
crosshead speed of 0.2 mm/min. Compressive strength (C)
was calculated by C= P/A, where P is the critical load and
A is the specimen cross-sectional area [28]. The flexural
strength of the specimens was measured by the three-point
flexural method with a span of 20 mm at a crosshead speed
of 0.5 mm/min. Flexural strength (S) was calculated by
S = 3 FL/2bd2, where F is the maximum load, L is flex-
ure span, b is specimen width, and d is specimen thick-
ness [29]. For each material, 12 specimens were tested
to determine these mechanical properties.
Isolation and culture of bone marrow MSCs
MSCs were harvested from the bone marrow of 4-week-
old New Zealand rabbits, using an extraction method simi-
lar to that described in Lim et al. [30] and Ouyang et al.
[31]. The bilateral posterior iliac crests of anesthetized
rabbit were disinfected, and 4 ml bone marrow was ex-
tracted from the bilateral iliac crests using a puncture nee-
dle with saline containing 1000 U/ml sodium heparin and
mixed with heparin. The anti-coagulated bone marrow was
diluted with 5 times the volume of low glucose Dulbecco’s
Modified Eagle Media (DMEM, Gibco, Rockville, MD,
USA). The bone marrow mixtures were centrifuged by
Percoll density gradient at 1800 rpm for 20 minutes at
room temperature, and the nucleated cell layer in the mid-
dle was carefully drawn out, added to the DMEM, and
cleaned by two 10-minute rounds of 1200 r/min centrifu-
gation. The bone marrow nucleated cells were harvested
and then resuspended in control media [DMEM supple-
mented with 10% fetal bovine serum (FBS, Gibco) and 1%
penicillin/streptomycin (Sigma Aldrich, St. Louis, MO,
USA)]. These cells were inoculated in T-75 cm2 flasks at a
density of 2 × 105 cells/cm2 in control DMEM and incu-
bated at 37°C in a 5% CO2 saturated humid incubator.After 48 hours, the media was changed for the first time
after washing twice with PBS to remove non-adherent
cells, and then the media was changed every 3 days.
When the cells approached confluence, the cell culture
supernatant in the flask was discarded, the cells were
washed two or three times with PBS, and 2.5 g/L tryp-
sin/ethylene diaminetetraacetic acid (Gibco) was added
for digestion. The cells were subcultured at a ratio of
1:3, and the third generation of cells was prepared for
downstream-related experiments. The animal protocol
used in the current study compliance with the relevant
laws and institutional guidelines, and also was approved
by the ethics review committee of the Third Xiangya
Hospital, Central South University.
Seeding of MSCs onto BCP and nHA-coated BCP scaffolds
Prior to cell culture, the BCP and nHA-coated BCP discs
were sterilized in a low temperature plasma sterilizer
(STERRAD 100S, Irvine, CA, USA). Immediately before
cell seeding, the nHA-coated BCP and BCP scaffolds
were soaked in osteogenic media [control media further
supplemented with 10 nmol/L dexamethasone (Sigma),
200 μmol/L L-ascorbic acid-2-phosphate (Sigma), and
10 mmol/L β-glycerol sodium phosphate (Sigma)] [32]
for 24 hours. MSCs were suspended in osteogenic
media. Twenty thousand cells diluted into 2 ml osteo-
genic media were added to each well of a 24-well culture
plate containing a BCP or nHA-coated BCP scaffold and
maintained in a 5% CO2 humidified incubator at 37°C.
The media was changed every 2 days.
FESEM of MSCs attached to scaffolds
After culture of MSCs on BCP or nHA-coated BCP scaf-
folds for 1 day, samples were washed with PBS, fixed
with 2.5% glutaraldehyde, dehydrated by an alcohol gra-
dient, soaked in osmium tetroxide, dried, and coated
with gold for observation by FESEM.
Cell proliferation
After 1 day or 14 days, the media was removed and the
cells cultured on BCP and nHA-coated BCP discs were
washed with PBS. The samples were treated with the dye
solutions of the LIVE/DEAD Cell Imaging kit (Molecular
Probes, Eugene, OR, USA) for 15 minutes at room
temperature for staining of live and dead cells. Green
fluorescent live cells and red fluorescent dead cells were
viewed by epifluorescence microscopy (IX71, Olympus).
Cell proliferation was calculated by measuring two pa-
rameters, the percentage of live cells (PLive) and cell at-
tachment (CAttach), according to previously established
methods [24,33]. Images were taken of three randomly se-
lected fields of view for each sample (3 fields of view × 10
samples = 30 photographs per scaffold type), and live and
dead cells were counted in each image. PLive was
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of the numbers of live and dead cells. CAttach represents
the number of live cells attached to the specimen and was
calculated by dividing the number of live cells by the sam-
ple area. It is important to consider both PLive and CAttach,
because PLive will be high if few dead cells are present even
if only a small number of live cells are present. By con-
trast, CAttach provides an absolute measure of cell survival
on the scaffolds.
MTT assay
Metabolic activity of the cells was analyzed using the
MTT mitochondrial reaction, which is based on the ability
of live cells to reduce a tetrazulium-based compound,
MTT, to a purplish formazan product. Cell viability is pro-
portional to the amount of dehydrogenase activity within
the cells. After 14 days, BCP and nHA-coated BCP cell
culture samples were transferred to new 24-well plates,
washed twice with PBS, and incubated in 1 ml PBS and
100 μl MTT (5 mg/ml) solution at 37°C for 4 hours. The
solution was then removed by aspiration, and 1 ml DMSO
was added to completely dissolve the formazan. Two
hundred-microliter samples of the final sample solutions
were transferred to 98-well plates, and absorbance at
490 nm was measured with a microplate reader (Wallac
Victor 31420 Multilabel Counter, Turku, Finland).
Osteogenic differentiation of MSCs on BCP and nHA-coated
BCP scaffolds
After 14 days of MCS culture on each scaffold type, the
culture supernatant in each well was aspirated, and the
samples were washed twice with PBS before transfer to a
new 24-well plate. In the new plate, 0.2 ml de-ionized dis-
tilled water was added to each well before storage at –20°C
overnight, followed by three freeze–thaw cycles (–80°C
and room temperature for 30 minutes each) to disrupt the
cell membrane. Samples were then transferred to 1.5-ml
centrifuge tubes and subjected to 5000 g centrifugation
at 4°C for 5 minutes before careful collection of the
supernatant.
Three osteogenic markers were detected: alkaline phos-
phatase (ALP), collagen type I (Coll I), osteocalcin (OC).
ALP activity, Coll I production, and OC production were
quantified using the Rabbit Total Alkaline Phosphatase
(TALP) enzyme-linked immunosorbent assay (ELISA) Kit,
the Rabbit Collagen Type I, Col I ELISA Kit, and the
Rabbit Osteocalcin/bone gla protein ELISA Kit (all from
Sino-American Biotechnology, Wuhan, China), respect-
ively, according to the manufacturer’s instructions. The
absorbance of the solution in each well was measured
using a microplate reader (Wallac Victor 31420 Multilabel
Counter) at 450 nm, and the ALP, Coll I, and OC concen-
trations were calculated according to standard curves
established based on the standard density as the abscissaand the optical density value as the ordinate, with MSCs
cultured on tissue culture plates in a control media serv-
ing as a control.Statistical analysis
All data obtained are presented as mean ± SD values.
One-way and two-way analyses of variance (ANOVAs)
were carried out to detect significant effects of the ex-
perimental variables. Tukey’s multiple comparison tests
were used with a P value of 0.05.Results
Microstructure characterization of BCP and nHA-coated
BCP scaffolds
Figure 1 shows the microstructures of a BCP scaffold,
nHA powder, and a nHA-coated BCP scaffold. In images
obtained by FESEM, macropores measuring from approxi-
mately 150 μm to almost 500 μm and containing many
micropores (<10 μm) were observed in the BCP scaffolds
(Figure 1A). The rod-like morphology observed in FETEM
images of the nHA indicated that the material was effect-
ively synthesized, with the length of individual crystals
ranging from 50 to 200 nm and the width ranging from
15 to 30 mm (Figure 1B). The low magnification image in
Figure 1C shows the nHA crystal layer deposited onto the
BCP surface. Similar nHA crystals were also observed on
the walls of pores within the BCP scaffold. The deposited
layer consisted of nano-crystals, as shown in the higher
magnification image in Figure 1D.
XRD analysis of the BCP and nHA-coated BCP ceramic
surfaces showed that the HA/TCP ratio was 65/35 on the
BCP surface and 100/0 on the nHA-coated BCP surface
(Figure 2), and the diffraction peak corresponding to the
coating was consistent with the HA standard card (card
no. 72-1243). These data indicate that the deposited HA
formed a complete layer on the BCP surface.
The density of the BCP ceramic was 1.51 ± 0.03 g/cm3,
and that of the nHA-coated BCP was 1.56 ± 0.04 g/cm3,
with no significant difference (P > 0.1) between the dens-
ities of these two ceramics (n = 12). Similarly, the porosi-
ties of the two ceramics were not significantly different
at 50.2% ± 1.1% and 48.7% ± 1.2% for BCP and nHA-
coated BCP, respectively (P > 0.1; n = 12).Mechanical properties of BCP and nHA-coated BCP
The compressive strengths of BCP and nHA-coated BCP
were 2.52 ± 0.22 MPa and 2.76 ± 0.18 MPa, respectively,
and these measurements were not significantly different
(P > 0.1) (n = 12). The flexural strengths of BCP and nHA-
coated BCP were 1.85 ± 0.3 MPa and 1.95 ± 0.31 MPa, re-
spectively, and these measurements also were not signifi-
cantly different (P > 0.1; n = 12).
Figure 1 Microstructure of the BCP scaffold, nHA powder, and the nHA-coated BCP scaffold. (A) FESEM image of a polished surface of a
BCP scaffold. (B) TEM micrograph of nHA powder. (C) Low magnification FESEM image displaying the formation of a nHA crystal deposition layer
on the BCP scaffold surface. Similar nHA crystals were also observed on the walls of pores within the BCP scaffold. (D) High magnification image
of the deposited nano-crystal layer.
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FESEM imaging showed an MSC (Figure 3A, MSC indi-
cated by arrow) adhered to a BCP scaffold. On the nHA-
coated scaffolds, MSCs also adhered and developed long
cytoplasmic extensions (Figure 3B, extensions noted as “E”)
attached to the scaffold surface. Figure 3C demonstratesFigure 2 XRD patterns for BCP and nHA-coated BCP ceramics.
The HA/TCP ratio was 65/35 without HA coating and 100/0 with
HA coating.how the cytoplasmic extensions (“E”) adhered to the nHA
crystals coating the BCP surface.
MSC proliferation and viability on BCP and nHA-coated
BCP scaffolds
Representative images of fluorescently stained live and
dead MSCs culture with BCP and nHA-coated BCP scaf-
folds after 1 and 14 days are shown in Figure 4. After the
MSCs and scaffolds were co-cultured for 1 day, living cells
(stained green) had adhered to both scaffold types and ex-
hibited normal polygonal morphology (Figure 4A,B), and
a few dead cells (stained red) were observed on the scaf-
folds (Figure 4C,D). After co-culture for 14 days, MSCs
had proliferated on these scaffolds, reaching confluence
on some areas, but not most, of the BCP scaffolds
(Figure 4E) and achieving a fully confluent monolayer on
the nHA-coated BCP scaffolds (Figure 4F). Although
MSC proliferation was clearly observed on both scaffold
types from days 1 to 14, after 14 days, the number of living
cells on the nHA-coated BCP scaffolds was greater than
that on the BCP scaffolds. After 14 days, the number of dead
cells on either scaffold type remained low (Figure 4G,H).
The percentages of live MSCs, PLive, cultured with
BCP and nHA-coated BCP scaffolds for 1 day and
14 days were plotted (Figure 5A). After 1 day, the PLive
of the BCP group was 86.4 ± 4.4%, and that of the nHA-
Figure 3 FESEM images of MSCs adhered to BCP and nHA-
coated BCP scaffolds. Arrow in (A) indicates an MSC adhered to
the BCP scaffold. (B) MSCs adhered to the nHA-coated BCP scaffold
and developed long cytoplasmic extensions attached to the scaffold
surface. (C) Cytoplasmic extensions (“E”) of an MSC adhered to the
nHA crystals coating the BCP surface.
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ference between the two materials (P > 0.05). After
14 days, the PLive of the BCP group was 98 ± 1.1%, and
that of the nHA-coated BCP group was 98.5 ± 0.5%, also
with no significant difference between the two materials
(P > 0.05). However, compared to the values on day 1,
the PLive values for both groups significantly increased
by day 14 (P < 0.05). Figure 5B shows the attachment re-
sults for MSCs cultured with BCP and nHA-coated BCP
scaffolds after 1 and 14 days. CAttach for BCP increased
from 62 ± 26 cells/mm2 after 1 day to 415 ± 62 cells/mm2
after 14 days (P < 0.05). For nHA-coated BCP, CAttach in-
creased from 63 ± 27 cells/mm2 after 1 day to 541 ± 35
cells/mm2 after 14 days (P < 0.05). After 14 days, CAttach
on nHA-coated BCP (541 ± 35 cells/mm2) was higher than
that on BCP (415 ± 62 cells/mm2) (P < 0.05). The results of
the MTT assay of MSC viability did show a significant dif-
ference between the two scaffold types, with absorbance
values of 1.00 ± 0.13 for the BCP group and 1.13 ± 0.09 for
the nHA-coated BCP group (P < 0.05) (n = 12).
Together, these data indicate that the nHA coating pro-
moted MSC proliferation and increased MSC viability.
ALP activity, Coll I production, and OC production of
MSCs on BCP and nHA-coated BCP scaffolds
As important markers of osteogenic differentiation [34],
ALP activity, Coll I production, and OC production were
measured for MSCs on BCP and nHA-coated BCP scaf-
folds (Figure 6). The ALP concentration (Figure 6A) mea-
sured for MSCs on nHA-coated BCP scaffold samples was
4.74 ± 0.38 U/L, which was significantly greater (P < 0.05)
than that for MSCs on BCP scaffold samples (4.15 ± 0.42
U/L). The ALP concentrations measured for both the
BCP and nHA-coated BCP groups were significantly
greater than that of the control group (1.46 ± 0.17 U/L;
P < 0.05) (n = 12). The Coll I concentration (Figure 6B)
measured for MSCs on nHA-coated BCP scaffold sam-
ples was 16.60 ± 1.25 μg/L, which was significantly
greater (P < 0.05) than that for MSCs on BCP scaffold
samples (13.71 ± 1.06 μg/L). The Coll I concentrations
measured for both the BCP and nHA-coated BCP
groups were significantly greater than that of the con-
trol group (9.74 ± 1.05 μg/L; P < 0.05) (n = 12). The OC
concentration (Figure 6C) measured for MSCs on
nHA-coated BCP scaffold samples was 478.04 ±
28.27 ng/L, which was significantly greater (P < 0.05)
than that for MSCs on BCP scaffold samples (388.02 ±
Figure 4 (See legend on next page.)
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Figure 4 Representative images of Live/Dead cell staining of MSCs cultured on BCP and nHA-coated BCP scaffolds. After 1 day in co-culture,
living cells (stained green) had adhered to both scaffold types, exhibiting normal polygonal morphology (A, B), and few dead cells (stained red) were
seen on either scaffold type (C, D). After co-culture for 14 days, MSCs had proliferated on both scaffold types. MSCs have not yet reached full confluence
on most regions of the BCP scaffolds (E), but they had achieved a fully confluent monolayer on the nHA-coated BCP scaffolds (F). After 14 days in
culture, few dead cells were seen on either scaffold type (G, H).
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the BCP and nHA-coated BCP groups were significantly
greater than that of the control group (115.53 ± 12.49 ng/L;
P < 0.05) (n = 12).
Discussion
Scaffold selection is a key point in bone tissue engineering,
and porous BCP ceramics offer many of the properties of
an ideal scaffold for bone tissue regeneration as summa-
rized by Porter et al. [2]. Specifically, porous BCP ceramics
are able to: “1) provide temporary mechanical support to
the affected area; 2) act as a substrate for osteoid de-
position; 3) contain a porous architecture to allow forFigure 5 MSC proliferation on the BCP and nHA-coated BCP
scaffolds. (A) Percentage of living cells, PLive. (B) Attachment density,
CAttach. PLive did not differ significantly between the BCP and nHA-
coated BCP groups at either day 1 or day 14, but did increase
significantly from day 1 to day 14 on both scaffold types. From day 1
to day 14, CAttach of MSCs on BCP and nHA-coated BCP scaffolds
increased 5.7- and 7.6-fold, respectively. Data are given as mean ± SD, and
n= 12 with dissimilar letters indicating a significant difference (P< 0.05).vascularization and bone in-growth; 4) encourage bone
cell migration into the scaffold; 5) degrade in a con-
trolled manner to facilitate load transfer to developing
bone; 6) produce non-toxic degradation products; 7)
not incite an active chronic inflammatory response; and
8) be sterilized without loss of bioactivity [2,10-12]”.
However, porous BCP ceramics lack the ability to sup-
port and promote osteogenic differentiation of bone
precursor cells within an implanted scaffold [11,13],
and therefore, this material is not able to induce satis-
factory bone formation and its clinical use has been
limited [9-11,14].
In this study, we coated conventional porous BCP cer-
amics with nHA to improve the material’s osteoinductive
potential and create a new bioresorbable ceramic scaffold
for application in bone tissue engineering. We found that
nHA coating of BCP scaffolds had little impact on the
porosity, density, and flexural and compressive strength of
BCP. A deposited layer of rod-like nHA was formed on
the BCP surface and pore walls, completely covering the
conventional porous BCP ceramic surface. Thus, the
hydrothermal deposition method used in this study was
able to form a coating layer of nHA on the BCP surface
that did not significantly change the physical and mechan-
ical properties of BCP. In addition, the hydrothermal de-
position method used in this study is simple, quick, and
does not require synthesis of a large amount of nHA to
coat the conventional porous BCP ceramics, which re-
duces material preparation costs. Even more importantly,
the biological characteristics of nHA-coated BCP are simi-
lar to those reported for nanostructured BCP [9,23].
To further investigate the osteoinductive potential of
nHA-coated BCP ceramics, we seeded MSCs on BCP and
nHA-coated BCP scaffolds and compared cell adhesion,
proliferation, and ALP activity on these two scaffold types.
After 1 day in culture, MSCs had attached and stretched,
exhibiting normal cell morphology on both scaffold types.
However, on the nHA-coated BCP scaffolds, MSCs
stretched more obviously than on the BCP scaffolds. MSC
spreading and development of cytoplasmic extensions in-
dicated good attachment and viability of MSCs on both
materials. MSCs greatly proliferated from day 1 to 14 in
culture, increasing in number by 5.7-fold on the BCP scaf-
folds and 7.6-fold on the nHA-coated BCP scaffolds, and
the number of living cells on the nHA-coated BCP scaf-
folds was greater than that on the BCP scaffolds. Further-
more, MTT assay results showed that cell viability on the
Figure 6 Osteogenic differentiation of MSCs cultured on BCP and
nHA-coated BCP scaffolds. (A) ALP activity, (B) Coll I production, and
(C) OC production. MSCs on nHA-coated BCP scaffolds produced
higher levels of these osteogenic markers than MSCs on BCP scaffolds
(P < 0.05), and the levels of ALP, Coll I, and OC production on both
scaffold types were significantly greater than those of the control
group. Data are given as mean ± SD, n =12 with dissimilar letters
indicating a significant difference (P < 0.05).
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scaffolds. Therefore, although both scaffolds can support
the adhesion and proliferation of MSCs over time in cul-
ture, the nHA-coated BCP scaffolds supported better
MSC proliferation, indicating that the nHA coating on the
BCP scaffold surface can promote MSC adhesion, prolifer-
ation, and viability, consistent with previous studies that
examined bone-related cell behavior on nHA [17-21,35].For example, Zandi et al. [20] reported that coating of
HA/gelatin scaffolds with nHA enabled better MSC at-
tachment and proliferation in comparison with noncoated
scaffolds. Chen et al. [21] reported that after a nHA layer
was coated onto a roughened titanium surface, the prolif-
eration of MSCs was higher than on the corresponding
noncoated titanium surfaces. A novel composite coupling
nHA and poly [4-methacryloyloxyethyl trimellitate an-
hydride (4-META)]-grafted silk fibroin (SF) described
by Korematsu [35] could improve L-929 cell adhesion and
bioactivity compared to the original SF due to a coating of
sintered nHA on 4-META -grafted SF.
In addition, the osteogenic markers ALP, Coll I, and OC
were expressed by MSCs cultured on the BCP and nHA-
coated BCP scaffolds, but MSCs on the nHA-coated BCP
scaffolds produced more ALP, Coll I, and OC than MSCs
on the BCP scaffolds. Based on these data, it seems that
the high numbers of attached MSCs, as well as their
osteogenic differentiation on nHA-coated BCP scaffolds,
were the result of the surface properties introduced by
nHA to the scaffold material’s surface. A possible mechan-
ism responsible for these effects on MSC proliferation and
osteogenic differentiation may be the small scale of the
scaffold surface nanostructure, which enhanced interfacial
adhesion of cells to nHA. The nanoscale surface structure
gives the BCP much greater surface area and reactivity,
which in turn enhances the scaffold’s ability to guide cell
mitogenic behavior [19,20,36,37].
In addition to the scale of the nHA surface structure, the
crystallinity of nHA particles also affects cell behavior, with
the surface chemistry and topography of lower crystallinity
being favorable for cell attachment and differentiation
[19,38]. The results of our study further support this no-
tion. Another possible mechanism responsible for the in-
creased MSC proliferation and ALP activity on nHA-
coated BCP scaffolds is that the nHA coating was partially
dissolved to release Ca2+ ions. Appropriate Ca2+ concentra-
tions have been shown to favor cell proliferation and differ-
entiation [19,39]. Therefore, the nHA powder synthesized
by a wet chemical method is suitable for use as a coating
material on porous BCP, and nHA shows more similarity
in terms of morphology and crystal structure to natural
apatite [Figure 1(B), and Figure 2 (coated with nHA)]. Fur-
ther studies should investigate the mineralization of MSCs
on nHA-coated BCP scaffolds and the osteoinductivity of
nHA-coated BCP in vivo.
Conclusions
In this study, for the first time, we coated porous BCP cer-
amic scaffolds with nHA and then induced the osteogenic
differentiation of rabbit bone marrow-derived MSCs
seeded on these scaffolds. The hydrothermal deposition
method used to apply nHA to the BCP scaffolds formed a
dense layer of rod-like nHA crystals on the BCP surface
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http://www.biomedcentral.com/1471-2474/15/114and on the pore walls. The nHA coating did not signifi-
cantly affect the density, porosity, flexural strength, or
compressive strength of the underlying BCP. Our results
demonstrate that BCP scaffolds coated with nHA were
more conducive for MSC adhesion, proliferation, and
osteogenic differentiation than conventional, uncoated
BCP scaffolds, indicating that nHA coating can enhance
the osteoinduction potential of BCP ceramics, making
this material more suitable for applications in bone tis-
sue engineering.
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